Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription Articles published in Cancer Epidemiol Biomarkers Prev Retrieve available abstracts of 26 articles: HTML format Text format

Single Articles

October 2019
1. SCHABATH MB, Cote ML
   Cancer Progress and Priorities: Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2019;28:1563-1579.
   PubMed     Text format    
   
   
   September 2019
2. D'ANTONA P, Cattoni M, Dominioni L, Poli A, et al
   Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer.
   Cancer Epidemiol Biomarkers Prev. 2019 Sep 5. pii: 1055-9965.EPI-19-0626.
   PubMed     Text format     Abstract available
   
   
   July 2019
3. KACHURI L, Helby J, Bojesen SE, Christiani DC, et al
   Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.
   Cancer Epidemiol Biomarkers Prev. 2019;28:1228-1237.
   PubMed     Text format     Abstract available
   
   
   April 2019
4. HUO J, Hong YR, Bian J, Guo Y, et al
   Low Rates of Patient-Reported Physician-Patient Discussion about Lung Cancer Screening among Current Smokers: Data from Health Information National Trends Survey.
   Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0629.
   PubMed     Text format     Abstract available
   
   
   
5. GRAFETSTATTER M, Husing A, Gonzalez Maldonado S, Sookthai D, et al
   Plasma Fibrinogen and sP-Selectin are associated with the risk of lung cancer in a prospective study.
   Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1285.
   PubMed     Text format     Abstract available
   
   
   March 2019
6. JONES CC, Bradford Y, Amos CI, Blot WJ, et al
   Cross-cancer pleiotropic associations with lung cancer risk in African Americans.
   Cancer Epidemiol Biomarkers Prev. 2019 Mar 20. pii: 1055-9965.EPI-18-0935.
   PubMed     Text format     Abstract available
   
   
   
7. MAGUIRE FB, Morris CR, Parikh-Patel A, Cress RD, et al
   Disparities in systemic treatment use in advanced-stage non-small cell lung cancer by source of health insurance.
   Cancer Epidemiol Biomarkers Prev. 2019 Mar 6. pii: 1055-9965.EPI-18-0823.
   PubMed     Text format     Abstract available
   
   
   February 2019
8. PALAZZO LL, Sheehan DF, Tramontano AC, Kong CY, et al
   Disparities and Trends in Rates of Genetic Testing and Erlotinib Treatment Among Metastatic Non-Small Cell Lung Cancer Patients.
   Cancer Epidemiol Biomarkers Prev. 2019 Feb 20. pii: 1055-9965.EPI-18-0917.
   PubMed     Text format     Abstract available
   
   
   
9. PETERS BA, Hayes RB, Goparaju C, Reid C, et al
   The microbiome in lung cancer tissue and recurrence-free survival.
   Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0966.
   PubMed     Text format     Abstract available
   
   
   January 2019
10. ZHU Y, Wei Y, Zhang R, Dong X, et al
    Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 30. pii: 1055-9965.EPI-18-0356.
    PubMed     Text format     Abstract available
    
    
    
11. LUSK CM, Wenzlaff AS, Watza D, Sieren JC, et al
    Quantitative imaging markers of lung function in a smoking population distinguish COPD sub-groups with differential lung cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0886.
    PubMed     Text format     Abstract available
    
    
    October 2018
12. NIU Y, Su M, Wu Y, Fu L, et al
    Circulating plasma microRNAs as potential biomarkers of non-small cell lung cancer obtained by high-throughput real-time PCR profiling.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 30. pii: 1055-9965.EPI-18-0723.
    PubMed     Text format     Abstract available
    
    
    
13. BROWN D, Zingone A, Yu Y, Zhu B, et al
    Relationship between circulating inflammation proteins and lung cancer diagnosis in the National Lung Screening Trial.
    Cancer Epidemiol Biomarkers Prev. 2018 Oct 8. pii: 1055-9965.EPI-18-0598.
    PubMed     Text format     Abstract available
    
    
    September 2018
14. GUO Y, Zhang R, Shen S, Wei Y, et al
    DNA Methylation of LRRC3B: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients.
    Cancer Epidemiol Biomarkers Prev. 2018 Sep 5. pii: 1055-9965.EPI-18-0454.
    PubMed     Text format     Abstract available
    
    
    August 2018
15. ERICKSON P, Gardner LD, Loffredo CA, St George DM, et al
    Racial and Ethnic Differences in the Relationship Between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.
    Cancer Epidemiol Biomarkers Prev. 2018 Aug 31. pii: 1055-9965.EPI-18-0366.
    PubMed     Text format     Abstract available
    
    
    May 2018
16. DOHERTY JA, Grieshober L, Houck JR, Barnett MJ, et al
    Telomere length and lung cancer mortality among heavy smokers.
    Cancer Epidemiol Biomarkers Prev. 2018 May 9. pii: 1055-9965.EPI-17-1183.
    PubMed     Text format     Abstract available
    
    
    March 2018
17. ROSS K, Kramer MR, Jemal A
    Geographic Inequalities in Progress against Lung Cancer among Women in the United States, 1990-2015.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 30. pii: 1055-9965.EPI-17-0934.
    PubMed     Text format     Abstract available
    
    
    
18. LIN J, Kamamia C, Brown D, Shao S, et al
    Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER population.
    Cancer Epidemiol Biomarkers Prev. 2018 Mar 12. pii: 1055-9965.EPI-17-0822.
    PubMed     Text format     Abstract available
    
    
    January 2018
19. ZHAO Y, Varn FS, Cai G, Xiao F, et al
    A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2018;27:86-95.
    PubMed     Text format     Abstract available
    
    
    October 2017
20. LUND JL, Sanoff HK, Peacock-Hinton S, Muss H, et al
    Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States.
    Cancer Epidemiol Biomarkers Prev. 2017 Oct 4. pii: cebp.0523.2017.
    PubMed     Text format     Abstract available
    
    
    July 2017
21. ARGIRION I, Weinstein SJ, Mannisto S, Albanes D, et al
    Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11. pii: cebp.0293.2017.
    PubMed     Text format     Abstract available
    
    
    June 2017
22. JONES CC, Bush WS, Crawford DC, Wenzlaff AS, et al
    Germline genetic variants and lung cancer survival in African Americans.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 15. pii: cebp.0998.2016.
    PubMed     Text format     Abstract available
    
    
    
23. BOSSE Y, Amos CI
    A decade of GWAS results in lung cancer.
    Cancer Epidemiol Biomarkers Prev. 2017 Jun 14. pii: cebp.0794.2016.
    PubMed     Text format     Abstract available
    
    
    April 2017
24. BOFFA DJ, Graf RP, Salazar MC, Hoag J, et al
    Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival.
    Cancer Epidemiol Biomarkers Prev. 2017 Apr 26. pii: cebp.0120.2017.
    PubMed     Text format     Abstract available
    
    
    
25. TORRE LA, Islami F, Siegel RL, Ward EM, et al
    Global Cancer in Women: Burden and Trends.
    Cancer Epidemiol Biomarkers Prev. 2017;26:444-457.
    PubMed     Text format     Abstract available
    
    
    March 2017
26. BOSSE Y, Sazonova O, Gaudreault N, Bastien N, et al
    Transcriptomic Microenvironment of Lung Adenocarcinoma.
    Cancer Epidemiol Biomarkers Prev. 2017;26:389-396.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: